Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
2 clinical trials · Condition
◉ Watch Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
| Record | Firm | Date |
|---|---|---|
| A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease (NCT06189495) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-12-30 |
| Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease (NCT03856853) | Beijing Continent Pharmaceutical Co, Ltd. | 2018-06-15 |
Track Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) automatically
Every clearance here is in the API, with alerts when new ones post.